ELEGANCE OPT.INT.HO.HD-10
Elegance Optical International Holdings Limited, an investment holding company, manufactures and trades in optical frames and sunglasses in Europe, the United States, the People's Republic of China, and internationally. The company operates through Trading, Property Investment, Debts and Securities Investment, Film Investment and Distribution, and Energy Business segments. The Trading segment eng… Read more
ELEGANCE OPT.INT.HO.HD-10 (5HW) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, ELEGANCE OPT.INT.HO.HD-10 (5HW) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
ELEGANCE OPT.INT.HO.HD-10 - Net Assets Trend (None–None)
This chart illustrates how ELEGANCE OPT.INT.HO.HD-10's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ELEGANCE OPT.INT.HO.HD-10 (None–None)
The table below shows the annual net assets of ELEGANCE OPT.INT.HO.HD-10 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to ELEGANCE OPT.INT.HO.HD-10's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
ELEGANCE OPT.INT.HO.HD-10 Competitors by Market Cap
The table below lists competitors of ELEGANCE OPT.INT.HO.HD-10 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jwwinvest
WAR:JWW
|
$707.16K |
|
SYSCO (SYY.SG)
STU:SYY
|
$707.57K |
|
SQZ Biotechnologies Company
PINK:SQZB
|
$707.79K |
|
Equity Story Group Ltd
AU:EQS
|
$708.17K |
|
Arqit Quantum Inc. Warrants
NASDAQ:ARQQW
|
$705.70K |
|
COGNIZANT TECH SO-A
BE:COZ
|
$705.29K |
|
Blue River Resources Ltd
PINK:BRVRF
|
$704.59K |
|
Global Cannabis Applications Corp
PINK:FUAPF
|
$704.00K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ELEGANCE OPT.INT.HO.HD-10's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares ELEGANCE OPT.INT.HO.HD-10's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently ELEGANCE OPT.INT.HO.HD-10 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares ELEGANCE OPT.INT.HO.HD-10's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $9,394,036,854
- Average return on equity (ROE) among peers: 4.98%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ELEGANCE OPT.INT.HO.HD-10 (5HW) | €- | N/A | N/A | $706.18K |
| Modern Dental Group Limited (1MD) | $2.36 Billion | 15.30% | 0.55x | $213.74 Million |
| SCHOTT Pharma AG & Co. KGaA (1SXP) | $709.04 Million | 17.68% | 0.69x | $475.06 Million |
| Alcon Inc. (2U3) | $19.26 Billion | 1.95% | 0.45x | $32.92 Billion |
| Shofu Inc. (69W) | $35.51 Billion | 8.83% | 0.23x | $217.64 Million |
| 7VG (7VG) | $176.36 Million | 14.92% | 1.12x | $658.78 Million |
| Bio-gate AG (BIG1) | $4.25 Million | -42.46% | 0.46x | $2.79 Million |
| Paul Hartmann AG (PHH2) | $690.37 Million | 10.65% | 0.81x | $783.58 Million |
| Sartorius AG VZO O.N. (SRT) | $497.08 Million | 9.76% | 1.56x | $6.63 Billion |
| Shandong Weigao Group Medical Polymer Company Limited (UK2) | $25.34 Billion | 8.16% | 0.37x | $1.27 Billion |